Temporal adaptive changes in contractility and fatigability of diaphragm muscles from streptozotocin-diabetic rats.
Diabetes is characterized by ventilatory depression due to decreased diaphragm (DPH) function. This study investigated the changes in contractile properties of rat DPH muscles over a time interval encompassing from 4 days to 14 weeks after the onset of streptozotocin-induced diabetes, with and without insulin treatment for 2 weeks. Maximum tetanic force in intact DPH muscle strips and recovery from fatiguing stimulation were measured. An early (4-day) depression in contractile function in diabetic DPH was followed by gradual improvement in muscle function and fatigue recovery (8 weeks). DPH contractile function deteriorated again at 14 weeks, a process that was completely reversed by insulin treatment. Maximal contractile force and calcium sensitivity assessed in Triton-skinned DPH fibers showed a similar bimodal pattern and the same beneficial effect of insulin treatment. While an extensive analysis of the isoforms of the contractile and regulatory proteins was not conducted, Western blot analysis of tropomyosin suggests that the changes in diabetic DPH response depended, at least in part, on a switch in fiber type.
Brotto
Marco
M
Muscle Biology Research Group (MUBIG), Schools of Nursing & Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA.
Brotto
Leticia
L
Jin
J-P
JP
Nosek
Thomas M
TM
Romani
Andrea
A
D000222:Adaptation, Physiological / Q000502:physiology*; D000704:Analysis of Variance; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D003964:Diaphragm / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D009119:Muscle Contraction; D018763:Muscle Fatigue; D020033:Protein Isoforms / Q000737:chemistry / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin; D014335:Tropomyosin / Q000737:chemistry / Q000378:metabolism
D020033:Protein Isoforms; D014335:Tropomyosin; D013311:Streptozocin
Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1875-9
8665049
Exp Physiol. 1998 Jul;83(4):481-7
9717070
Am J Physiol Cell Physiol. 2009 Apr;296(4):C930-40
19158402
Can J Physiol Pharmacol. 1991 Jun;69(6):852-8
1913331
Cell Res. 2004 Oct;14(5):373-8
15538969
Acta Neurol Scand. 1999 Oct;100(4):211-20
10510679
Exp Physiol. 2002 Jan;87(1):77-82
11805861
Am J Physiol Cell Physiol. 2006 Feb;290(2):C567-76
16192301
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):624-32
11254515
Am J Physiol Cell Physiol. 2009 Sep;297(3):C556-70
19625612
Semin Neurol. 1996 Jun;16(2):173-8
8987131
Diabetes. 1994 May;43(5):622-8
8168636
Ann Intern Med. 1996 Jan 1;124(1 Pt 2):97-103
8554221
Ann Fr Anesth Reanim. 1989;8 Suppl:R137
2604096
Exp Physiol. 2005 May;90(3):417-25
15728139
J Appl Physiol (1985). 1996 Aug;81(2):731-7
8872640
Adv Exp Med Biol. 2001;502:13-20
11950134
J Cell Biol. 2006 Aug 28;174(5):639-45
16943181
Cardiovasc Res. 1993 Mar;27(3):447-52
8490945
J Appl Physiol (1985). 2002 Jul;93(1):201-6
12070206
Pflugers Arch. 2001 Aug;442(5):738-44
11512030
Am J Physiol Cell Physiol. 2007 Mar;292(3):C1192-203
17108008
J Mol Cell Cardiol. 1989 Dec;21(12):1293-304
2632812
Diabetes Care. 2007 Apr;30(4):795-800
17259481